NCT/Study#
NCT04990102 /
CPX351/VYXEOS
Phase IB/II of CPX-351 as maintenance therapy in AML patients ineligible for bone marrow transplantation
DISEASE GROUP:
Leukemia
current phase:
Phase I/II
STUDY STATUS:
Enrolling
Location:
Hackensack, NJ
For More information:
